PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 233 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $253,000 | +15.0% | 5,577 | +10.4% | 0.02% | -8.3% |
| Q2 2019 | $220,000 | -7.9% | 5,053 | -9.0% | 0.02% | -29.4% |
| Q4 2018 | $239,000 | -24.6% | 5,550 | -13.7% | 0.03% | -10.5% |
| Q3 2018 | $317,000 | +51.0% | 6,430 | -1.8% | 0.04% | +35.7% |
| Q2 2018 | $210,000 | -99.8% | 6,547 | +340.9% | 0.03% | -12.5% |
| Q2 2014 | $136,412,000 | – | 1,485 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |